Skip to main content

Find Clinical Trials

Home
Conditions
Leukemia, Myeloid

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

91 public trials 18 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia

NCT01380756

Conditions: Cancer, Hematologic Diseases, Hematologic Malignancies, +8 more
Locations: Research Site Stony Brook, New York, United States

Research Site Cleveland, Ohio, United States

Research Site Houston, Texas, United States

View Trial Details

Completed

An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies

NCT01677780

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +15 more
Locations: Sarcoma Oncology Center Santa Monica, California, United States

M.D Anderson Cancer Center; Oncology Houston, Texas, United States

Cancer Therapy & Research Ctr; Dept Institute for Drug Development San Antonio, Texas, United States

Princess Margaret Hospital, Medical Oncology & Haematology Toronto, Ontario, Canada

View Trial Details

Completed

Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations

NCT00943943

Conditions: Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease

NCT01174940

Conditions: Bone Marrow Diseases, Graft Versus Host Disease, Graft vs Host Disease, +17 more
Locations: University of Kansas Medical Center Kansas City, Kansas, United States

View Trial Details

Completed

Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic Leukemias

NCT01144793

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS

NCT00025662

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +31 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus

NCT00133367

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Graft vs Host Disease, +27 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients

NCT01511289

Conditions: Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations: Local Institution Jakarta, Indonesia

Local Institution Batangas, Philippines

Local Institution Manila, Philippines

Local Institution Busan, South Korea

View all 22 locations

View Trial Details

Completed

A Study Of Panobinostat In Children With Refractory Hematologic Malignancies

NCT01321346

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +20 more
Locations: Childrens Hospital Los Angeles Los Angeles, California, United States

UCSF School of Medicine San Francisco, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

University of Miami Cancer Center Miami, Florida, United States

View all 20 locations

View Trial Details

Completed

Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701)

NCT00034684

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +22 more
Locations: Not specified

View Trial Details